Overview
Financials
Revenue history (in m)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 229 days late). All were audited by a statutory auditor.
- 202622/10/2026
- 202527/11/2025
- 202404/11/2024
- 202316/11/2023
- 202220/10/2022
- 202101/09/2022
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2026.
Results vs industry
Industry
Public procurement
278 tenders recorded as contractor: 57 national ($1,301,826) and 221 EU ($11,753,936).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 29, 2026 | Supply of medicines | $6,348$6,348 | Zespół Opieki Zdrowotnej w Oławie | |
| Oct 20, 2026 | Supply of medicinal products divided into 28 lots for the needs of SPSK im. Prof. Witolda Orłowskiego CMKP | $8,920$8,920 | Samodzielny Publiczny Szpital Kliniczny Im. Prof. W. Orłowskiego Centrum Medycznego Kształcenia Podyplomowego | |
| Oct 19, 2026 | Medicines 28 | $50,062$50,062 | Samodzielny Publiczny Szpital Kliniczny Im.Andrzeja Mielęckiego Śląskiego Uniwersytetu Medycznego w Katowicach |
Trademarks
MIP Pharma Polska holds 6 active trademarks registered with the Polish Patent Office. 1 application is pending. 1 mark has expired or was not registered. The first mark was filed in 2003.
| Mark | Protected until | |
|---|---|---|
| Velmea-MIP(word) | Sep 27, 2031 | |
| Arthromed(word) | Dec 8, 2035 | |
| Olopeg(word) | Jun 27, 2033 | |
| Myopam(word) | May 30, 2033 | |
| Hepochron(word) | May 30, 2033 |
Authorized Representatives
Manner of representation
Each member of the management board independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mip Pharma Gmbh | 100 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2003-11-01.
22 2490 0005 0000 4600 9046 6983- 13 2490 0005 0000 4600 0010 8929
24 1090 2851 0000 0001 4208 1011
Debt
No entries in the National Debtors Register (KRZ).
Secured liabilities
| Type | Creditor | |
|---|---|---|
Registered pledge | RV AIP S.C.S. SICAV-SIF |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 6, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | PREZYDENT MIASTA GDAŃSK |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Livistosp. z o.o. | $17,956,135.04 | livisto.pl | ||
| Informer Medsp. z o.o. | $16,392,492.79 | informermed.eu | ||
| Ursapharm Polandsp. z o.o. | $16,296,973.60 | ursapharm.pl | ||
| Przedsiębiorstwo Handlowo-Usługowe Technomexsp. z o.o. | $17,488,656.37 | technomex.eu | ||
| Qpharmasp. z o.o. | $16,010,159.04 | qpharma.pl | ||
| Vetdirectsp. z o.o. + limited partnership | $14,891,648.32 | vetdirect.pl | ||
| ODA Medicalsp. z o.o. | $9,414,794.43 | odamedical.pl | ||
| Diather Petrusewiczsp. k. | $7,399,375.09 | diather.pl | ||
| Acusticasp. z o.o. | $5,053,356.83 | bernafon.pl | ||
| Efmed Prosp. z o.o. | $4,777,802.25 | efmed.pl |
Change history
| Date | Event | |
|---|---|---|
| 2003-02-21 | Address change (Nowogrodzka 42/15, 00-695, Warszawa → Orzechowa 5, 80-175, Gdańsk) | |
| 2001-09-17 | Entered in the register |
FAQ
Last updated: 2026-10-22